Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, T-Cell, Peripheral 6Hematologic Neoplasms 4Urinary Bladder Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thyroid Neoplasms 2Parathyroid Neoplasms 2Otorhinolaryngologic Neoplasms 2Osteosarcoma 2Neoplasms 2Multiple Myeloma 2Mixed Tumor, Mesodermal 2Mesothelioma, Cystic 2Mesothelioma 2Lymphoma, T-Cell 2Lymphoma 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Chondrosarcoma 2Carcinoma, Small Cell 2Breast Neoplasms 2Adenosarcoma 2

Interventions

Paclitaxel 2Carboplatin 2zenocutuzumab 1pertuzumab 1pemigatinib 1olaparib 1ivosidenib 1ipatasertib 1entrectinib 1cobimetinib 1belinostat 1atezolizumab 1alectinib 1Vemurafenib 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mebendazole 1Immunotherapy 1HhAntag691 1Gemcitabine 1Erlotinib Hydrochloride 1Drug Therapy 1Cisplatin 1CP protocol 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms, Unknown Primary × belinostat × Clear all
NCT00873119 2015-07-28

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Valerio Therapeutics

Phase 2 Completed
89 enrolled 12 charts
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡